Hsbc Holdings PLC Blueprint Medicines Corp Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 31,814 shares of BPMC stock, worth $2.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,814

Previous 9,964 219.29%

Holding current value

$2.82 Million

Previous $1.07 Million 174.09%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $1.84 Million - $2.63 Million	21,850 Added 219.29%	31,814 $2.94 Million
Q2 2024 Aug 12, 2024	BUY	$85.18 - $108.78 $848,733 - $1.08 Million	9,964 New	9,964 $1.07 Million
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $16,227 - $22,836	-346 Reduced 5.58%	5,856 $294,000
Q2 2023 Aug 11, 2023	SELL	$42.2 - $66.37 $385,623 - $606,489	-9,138 Reduced 59.57%	6,202 $391,000
Q1 2023 May 15, 2023	SELL	$37.97 - $50.0 $304,481 - $400,950	-8,019 Reduced 34.33%	15,340 $690,000
Q4 2022 Feb 14, 2023	BUY	$41.06 - $66.48 $175,285 - $283,803	4,269 Added 22.36%	23,359 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $971,787 - $1.51 Million	-19,463 Reduced 50.48%	19,090 $1.28 Million
Q2 2022 Aug 11, 2022	BUY	$45.23 - $70.15 $582,200 - $902,970	12,872 Added 50.12%	38,553 $1.99 Million
Q1 2022 May 16, 2022	BUY	$54.1 - $110.08 $1.39 Million - $2.83 Million	25,681 New	25,681 $1.66 Million
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $348,819 - $429,278	-3,701 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$80.98 - $109.47 $200,668 - $271,266	-2,478 Reduced 40.1%	3,701 $382,000
Q2 2021 Aug 13, 2021	BUY	$82.78 - $101.0 $149,583 - $182,507	1,807 Added 41.33%	6,179 $543,000
Q1 2021 May 14, 2021	SELL	$90.71 - $108.28 $294,626 - $351,693	-3,248 Reduced 42.62%	4,372 $425,000
Q4 2020 Feb 12, 2021	BUY	$92.08 - $124.48 $701,649 - $948,537	7,620 New	7,620 $854,000
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $183,780 - $255,654	-2,521 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$73.54 - $97.8 $18,679 - $24,841	-254 Reduced 9.15%	2,521 $238,000
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $135,142 - $240,314	2,775 New	2,775 $222,000

Others Institutions Holding BPMC

# of Institutions

350

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.3B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Blueprint Medicines Corp Transaction History